Unique ID issued by UMIN | UMIN000029186 |
---|---|
Receipt number | R000033356 |
Scientific Title | Efficacy of six-minutes walk test(6MWT) and four meter gait test(4MGT) for stable interstitial pneumonia patient: a prospective observational study |
Date of disclosure of the study information | 2017/09/20 |
Last modified on | 2018/02/20 13:21:33 |
Efficacy of six-minutes walk test(6MWT) and four meter gait test(4MGT) for stable interstitial pneumonia patient: a prospective observational study
Study of 6MWT and 4MGT for IP patient
Efficacy of six-minutes walk test(6MWT) and four meter gait test(4MGT) for stable interstitial pneumonia patient: a prospective observational study
Study of 6MWT and 4MGT for IP patient
Japan |
Interestitial Pneumonia(IP)
Pneumology |
Others
NO
This is a prospective observational study for evaluation of the efficacy and correlation of six-minutes walk test(6MWT)and four meter gait test(4MGT), exercise capacity, muscle weakness, dyspnea, and health-related QOL score in stable Interstitial pneumonia(IP) patient.
Efficacy
Not applicable
Correlation of 6MWT score and 4MGT score
Correlation of 4MGT and following items
1. Patient profile(age, sex, Height, Body weight, BMI, smoking history, Classification of IP, and treatment)
2. Patients' vital signs(pulse rate, blood pressure, respiration rate, SpO2)
3. Arterial blood gas analysis(pH, PaO2, PaCO2)
4. Pulmonary function(FVC, FEV1.0, DLCO)
5. Muscle weakness(grip, triceps)
6. Skeletal muscle mass index(SMI)
7. Total modified-Medical Reserch Council(mMRC) dyspnea scale score
8. Total St. George's Respiratory Questionaire (SGRQ) score, and each component score
(symptom score, activity score, and impact score)
9. Total COPD Assessment Test(CAT) score
10. Physical Activities
Observational
18 | years-old | <= |
Not applicable |
Male and Female
1. Patients who are clinically or pathologically diagnosed Interstitial Pneumonia(IP) with the ATS/ERS criteria.
2. Patients who agree to participate in the study with the written informed consent.
1. Patients who diagnosed COPD or Bronchial Asthma.
2. Patients with uncontrolled cardiovascular disease, arrhythmia, or cerebrovascular disease.
3. Patients with skeletal of joint disease and cannot walk.
4. Patients with cognitive impairment or mental disorder and are regarded as impossible to answer the questionnaire of this study.
5. Patients who have experienced a IP exacerbation within the past one month.
6. Any other cases who are regarded as inadequate for the study enrollment by the investigators.
50
1st name | |
Middle name | |
Last name | Keisuke Tomii |
Kobe City Medical Center General Hospital
Department of Respiratory Medicine
2-1-1 Minatojima-minamimachi, Chuo-ku, Kobe
078-302-4321
ktomii@kcho.jp
1st name | |
Middle name | |
Last name | Ryosuke Hirabayashi |
Kobe City Medical Center General Hospital
Department of Respiratory Medicine
2-1-1 Minatojima-minamimachi, Chuo-ku, Kobe
078-302-4321
rhirabayashi0405@kcho.jp
Kobe City Medical Center General Hospital
Department of Respiratory Medicine
We have no funding.
Other
NO
2017 | Year | 09 | Month | 20 | Day |
Unpublished
No longer recruiting
2017 | Year | 09 | Month | 01 | Day |
2017 | Year | 10 | Month | 02 | Day |
2018 | Year | 02 | Month | 20 | Day |
2018 | Year | 02 | Month | 20 | Day |
This study targets on the IP outpatients who attend to Department of Respirology Medicine at Kobe City Medical Center General Hospital, from 2017/9/1 to 2018/2/28.
2017 | Year | 09 | Month | 19 | Day |
2018 | Year | 02 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033356